Since 2013, the Cancer Hospital of the Chinese Academy of Medical Sciences has adopted VENTANA anti-BRAF V600E (VE1) Mouse Monoclonal Primary Antibody as one of the standard reagents for the IHC method of detecting BRAF V600E mutations. The gene discussed is BRAF; the disease is cancer.